Shares of Danish pharmaceutical giant Novo Nordisk plummeted more than 22% on Friday after reporting results in a late-stage trial that missed expectations.
Related Posts
Zhipu AI Just Released GLM-4.5 Series: Redefining Open-Source Agentic AI with Hybrid Reasoning
The landscape of AI foundation models is evolving rapidly, but few entries have been as significant in 2025 as the…
Tesla says it made its first driverless delivery of a new car to a customer
Tesla shared a video showing its first driverless delivery of a car to a customer.
Google stock jumps 8% after search giant avoids worst-case penalties in antitrust case
The ruling comes nearly a year after a U.S. judge ruled that Google holds an illegal monopoly in its core…